Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Clin Cancer Res. 2017 Oct 24;24(1):217–223. doi: 10.1158/1078-0432.CCR-17-1555

Table 2.

Multivariable prognostic model for RCC incorporating MVD

Variable HR (95% CI) p-value
Age ≥ median (56) 1.67 (1.11-2.50) 0.013
Male gender 1.20 (0.79-1.82) 0.39
Performance status (1 vs. 0) 1.57 (0.99-2.47) 0.054
T stage (T3/T4 vs. T1/T2) 1.63 (0.98-2.70) 0.060
N stage (N+ vs. N0/NX) 2.95 (1.66-5.24) <0.001
Fuhrman grade (3/4 vs. 1/2) 2.07 (1.32-3.25) 0.001
Vascular invasion 1.52 (0.98-2.36) 0.064
MVD (high vs. low) 0.61 (0.41-0.90) 0.013